253 related articles for article (PubMed ID: 6086691)
21. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases.
Mandla S; Jones G; Tenenhouse HS
J Clin Endocrinol Metab; 1992 Apr; 74(4):814-20. PubMed ID: 1548347
[TBL] [Abstract][Full Text] [Related]
22. Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone.
Liberman UA; Eil C; Holst P; Rosen JF; Marx SJ
J Clin Endocrinol Metab; 1983 Nov; 57(5):958-62. PubMed ID: 6311866
[TBL] [Abstract][Full Text] [Related]
23. A variant form of the 1,25-dihydroxyvitamin D3 receptor with low apparent hormone affinity in cultured monkey kidney cells (LLC-MK2). A model for tissue resistance to vitamin D.
Kelly MA; Marion SL; Donaldson CA; Pike JW; Haussler MR
J Biol Chem; 1985 Feb; 260(3):1545-9. PubMed ID: 2981861
[TBL] [Abstract][Full Text] [Related]
24. 1,25-Dihydroxyvitamin D3 receptors: altered functional domains are associated with cellular resistance to vitamin D3.
Pike JW; Allegretto EA; Kelly MA; Donaldson CA; Marion SL; Mangelsdorf DJ; Haussler MR
Adv Exp Med Biol; 1986; 196():377-90. PubMed ID: 3012980
[TBL] [Abstract][Full Text] [Related]
25. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
[TBL] [Abstract][Full Text] [Related]
26. Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene.
Forghani N; Lum C; Krishnan S; Wang J; Wilson DM; Blackett PR; Malloy PJ; Feldman D
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):843-50. PubMed ID: 21073129
[TBL] [Abstract][Full Text] [Related]
27. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor.
Malloy PJ; Wang J; Srivastava T; Feldman D
Mol Genet Metab; 2010 Jan; 99(1):72-9. PubMed ID: 19815438
[TBL] [Abstract][Full Text] [Related]
28. Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor.
Barsony J; McKoy W; DeGrange DA; Liberman UA; Marx SJ
J Clin Invest; 1989 Jun; 83(6):2093-101. PubMed ID: 2542381
[TBL] [Abstract][Full Text] [Related]
29. Specific 1,25-hydroxycholecalciferol receptors and stimulation of 25-hydroxycholecalciferol-24R hydroxylase in human amniotic cells.
Delvin EE; Pilon AM; Vekemans M
Pediatr Res; 1987 May; 21(5):432-5. PubMed ID: 3035472
[TBL] [Abstract][Full Text] [Related]
30. Modulation of 1,25-dihydroxyvitamin D3 receptor binding and action by sodium butyrate in cultured pig kidney cells (LLC-PK1).
Costa EM; Feldman D
J Bone Miner Res; 1987 Apr; 2(2):151-9. PubMed ID: 2843001
[TBL] [Abstract][Full Text] [Related]
31. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.
Malloy PJ; Hochberg Z; Tiosano D; Pike JW; Hughes MR; Feldman D
J Clin Invest; 1990 Dec; 86(6):2071-9. PubMed ID: 2174914
[TBL] [Abstract][Full Text] [Related]
32. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism.
Tomon M; Tenenhouse HS; Jones G
Endocrinology; 1990 Jun; 126(6):2868-75. PubMed ID: 2351099
[TBL] [Abstract][Full Text] [Related]
33. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Bliziotes MM; Nanes M
Clin Endocrinol (Oxf); 1986 Oct; 25(4):373-81. PubMed ID: 3040300
[TBL] [Abstract][Full Text] [Related]
35. 1,25-Dihydroxyvitamin D3 receptors and functions in cultured pig kidney cells (LLC PK1). Regulation of 24,25-dihydroxyvitamin D3 production.
Colston K; Feldman D
J Biol Chem; 1982 Mar; 257(5):2504-8. PubMed ID: 6277901
[TBL] [Abstract][Full Text] [Related]
36. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
[TBL] [Abstract][Full Text] [Related]
37. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
38. Studies on an adherent variant of the human promyelomonocytic HL60 leukaemia cell line that constitutively expresses 25-hydroxyvitamin D3-24-hydroxylase activity which is inhibited by 1 alpha,25-dihydroxyvitamin D3.
Hayes ME; Bayley D; Mawer EB
J Mol Endocrinol; 1991 Dec; 7(3):185-95. PubMed ID: 1777040
[TBL] [Abstract][Full Text] [Related]
39. Effects of 1,25-dihydroxyvitamin D3 and phorbol ester on 25-hydroxyvitamin D3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells.
Chen ML; Boltz MA; Armbrecht HJ
Endocrinology; 1993 Apr; 132(4):1782-8. PubMed ID: 7681765
[TBL] [Abstract][Full Text] [Related]
40. Biological activity of 19-nor, 10-keto, 25-hydroxyvitamin D3.
Gray TK; Kleckner NW; Malloy PJ; Feldman D; Sivam G; Dodd RC; Cohen MS
J Bone Miner Res; 1987 Oct; 2(5):413-9. PubMed ID: 3455623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
